SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-020040
Filing Date
2022-07-21
Accepted
2022-07-21 16:34:07
Documents
13
Period of Report
2022-07-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38472
2 ex3-1.htm EX-3.1 5613
  Complete submission text file 0001493152-22-020040.txt   217991

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE indp-20220720.xsd EX-101.SCH 2965
4 XBRL LABEL FILE indp-20220720_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE indp-20220720_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3609
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 221097462
SIC: 2834 Pharmaceutical Preparations